Head-to-head · WeighScore
Kova vs Omzo
The verdict
Omzo takes it — 54.2/100 to 44.3/100.
Omzo grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Omzo is a multi-pillar telehealth service (weight loss, women's hormone health, sexual health, hair, skin, daily health) offering clinician-guided compounded GLP-1 — semaglutide and tirzepatide — with free…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Kova | Omzo |
|---|---|---|
| WeighScore | 44.3/100 | 54.2/100 |
| Grade | C | C |
| Scorecard rank | #498 | #459 |
| Semaglutide | Not disclosed | Not disclosed |
| Tirzepatide | Not disclosed | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #498 · C
Strengths
- Publishes the full price ladder for all three plan terms — intro month and renewal rate — directly in its FAQ
- Medication is included in the plan price, with no separate pharmacy charge
- States plainly that its compounded GLP-1s are 'not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality'
- Companion app tracks weight, protein and side effects, with medication schedule reminders
- You are not charged unless a provider approves treatment
Where it loses points
- At $449 per 4 weeks, the standing 1-month plan is among the most expensive compounded GLP-1 options we track
- The advertised $129 is the 6-month plan's intro month only — that plan then renews at $1,794 every 24 weeks
- Billed every 4 weeks rather than monthly, which is 13 charges a year instead of 12
- Never names which GLP-1 molecule is dispensed — only 'compounded, non-FDA-approved GLP-1 medications'
- No pharmacy or prescribing medical group is named anywhere on the site
Graded #459 · C
Strengths
- Compounded GLP-1 (semaglutide and tirzepatide) with clinician guidance
- Free, discreet delivery on all treatments
- FSA/HSA eligible
- Multi-pillar: also women's hormone, sexual health, hair, skin, and daily health
Where it loses points
- Pricing not published on the site — shown only after the intake quiz
- Compounding pharmacy partner not named (states only 'independent state-licensed')
- States of operation not published
- Not LegitScript-certified (no certification displayed)
- Legal entity not named; governing law given only as 'the state in which Omzo operates'
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.